Concepts (156)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Morphine | 1 | 2017 | 71 | 0.69 | Why? |
| Naloxone | 1 | 2017 | 153 | 0.63 | Why? |
| Brain Injuries, Traumatic | 5 | 2019 | 381 | 0.61 | Why? |
| Data Interpretation, Statistical | 1 | 2017 | 657 | 0.51 | Why? |
| Erythropoietin | 3 | 2019 | 167 | 0.47 | Why? |
| Blood Preservation | 2 | 2018 | 191 | 0.31 | Why? |
| Research | 1 | 2019 | 2115 | 0.31 | Why? |
| Communicable Diseases | 1 | 2019 | 2148 | 0.27 | Why? |
| Erythrocyte Transfusion | 2 | 2018 | 386 | 0.26 | Why? |
| Respiration, Artificial | 4 | 2021 | 22116 | 0.22 | Why? |
| Disease Management | 1 | 2019 | 6841 | 0.21 | Why? |
| Lung Compliance | 1 | 2021 | 243 | 0.20 | Why? |
| Hypothermia, Induced | 2 | 2018 | 176 | 0.19 | Why? |
| Patient Care Bundles | 1 | 2020 | 137 | 0.19 | Why? |
| Epoetin Alfa | 1 | 2018 | 13 | 0.19 | Why? |
| Biomedical Research | 1 | 2019 | 5270 | 0.18 | Why? |
| Stomach Ulcer | 1 | 2018 | 101 | 0.18 | Why? |
| Injections, Spinal | 1 | 2017 | 61 | 0.18 | Why? |
| Hematinics | 1 | 2018 | 48 | 0.18 | Why? |
| Biliary Tract Surgical Procedures | 1 | 2017 | 32 | 0.18 | Why? |
| Drug Therapy | 1 | 2020 | 280 | 0.17 | Why? |
| Histamine H2 Antagonists | 1 | 2018 | 111 | 0.17 | Why? |
| Respiratory Insufficiency | 2 | 2020 | 7301 | 0.17 | Why? |
| Decompressive Craniectomy | 1 | 2016 | 72 | 0.16 | Why? |
| Double-Blind Method | 5 | 2019 | 5988 | 0.16 | Why? |
| Neuroprotective Agents | 1 | 2019 | 240 | 0.16 | Why? |
| Hypercapnia | 1 | 2017 | 172 | 0.15 | Why? |
| Disease Transmission, Infectious | 1 | 2019 | 9044 | 0.15 | Why? |
| Sample Size | 1 | 2017 | 518 | 0.15 | Why? |
| Intracranial Hypertension | 1 | 2016 | 111 | 0.15 | Why? |
| Hepatectomy | 1 | 2017 | 276 | 0.14 | Why? |
| Infusions, Intravenous | 1 | 2017 | 1224 | 0.13 | Why? |
| Proton Pump Inhibitors | 1 | 2018 | 377 | 0.13 | Why? |
| Body Temperature | 1 | 2018 | 875 | 0.12 | Why? |
| Kaplan-Meier Estimate | 2 | 2019 | 4260 | 0.12 | Why? |
| Erythrocytes | 1 | 2018 | 617 | 0.12 | Why? |
| Positive-Pressure Respiration | 1 | 2019 | 1160 | 0.11 | Why? |
| Evidence-Based Medicine | 2 | 2020 | 3228 | 0.10 | Why? |
| Hydrocortisone | 1 | 2020 | 1790 | 0.10 | Why? |
| Communicable Disease Control | 1 | 2019 | 29620 | 0.10 | Why? |
| Out-of-Hospital Cardiac Arrest | 1 | 2018 | 1047 | 0.09 | Why? |
| Cardiopulmonary Resuscitation | 2 | 2018 | 1876 | 0.09 | Why? |
| Community-Acquired Infections | 1 | 2020 | 2328 | 0.09 | Why? |
| Critical Illness | 3 | 2020 | 17281 | 0.08 | Why? |
| Heart Arrest | 1 | 2017 | 1239 | 0.08 | Why? |
| Survival Analysis | 1 | 2019 | 7592 | 0.08 | Why? |
| Chloroquine | 1 | 2021 | 3152 | 0.08 | Why? |
| Europe | 2 | 2021 | 12702 | 0.08 | Why? |
| Randomized Controlled Trials as Topic | 3 | 2021 | 10649 | 0.07 | Why? |
| Critical Care | 3 | 2021 | 14081 | 0.06 | Why? |
| Intensive Care Units | 5 | 2021 | 29594 | 0.06 | Why? |
| Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 2020 | 73 | 0.06 | Why? |
| New Zealand | 2 | 2018 | 2073 | 0.06 | Why? |
| Chromosomes, Human, Pair 19 | 1 | 2020 | 77 | 0.06 | Why? |
| Anti-Inflammatory Agents | 1 | 2020 | 6153 | 0.06 | Why? |
| Venous Thrombosis | 1 | 2016 | 2739 | 0.05 | Why? |
| Physicians | 1 | 2020 | 4214 | 0.05 | Why? |
| Trypsin Inhibitors | 1 | 2020 | 38 | 0.05 | Why? |
| Chromosomes, Human, Pair 12 | 1 | 2020 | 84 | 0.05 | Why? |
| Chromosomes, Human, Pair 21 | 1 | 2020 | 90 | 0.05 | Why? |
| TYK2 Kinase | 1 | 2020 | 116 | 0.05 | Why? |
| Citrulline | 1 | 2020 | 36 | 0.05 | Why? |
| Receptors, CCR2 | 1 | 2020 | 103 | 0.05 | Why? |
| Humans | 24 | 2021 | 930598 | 0.05 | Why? |
| Influenza, Human | 3 | 2020 | 10779 | 0.05 | Why? |
| Pneumonia | 1 | 2020 | 5652 | 0.05 | Why? |
| Treatment Outcome | 7 | 2020 | 51732 | 0.05 | Why? |
| 2',5'-Oligoadenylate Synthetase | 1 | 2020 | 205 | 0.05 | Why? |
| Multigene Family | 1 | 2020 | 377 | 0.05 | Why? |
| Pandemics | 7 | 2020 | 389249 | 0.05 | Why? |
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2020 | 229 | 0.05 | Why? |
| Diabetes Mellitus | 1 | 2021 | 8207 | 0.05 | Why? |
| Receptor, Interferon alpha-beta | 1 | 2020 | 610 | 0.05 | Why? |
| Peptides, Cyclic | 1 | 2020 | 223 | 0.05 | Why? |
| Abbreviated Injury Scale | 1 | 2017 | 22 | 0.05 | Why? |
| Venous Thromboembolism | 1 | 2016 | 4273 | 0.04 | Why? |
| Early Termination of Clinical Trials | 1 | 2020 | 1256 | 0.04 | Why? |
| Male | 12 | 2021 | 367725 | 0.04 | Why? |
| Female | 12 | 2021 | 380317 | 0.04 | Why? |
| Pulmonary Embolism | 1 | 2016 | 4775 | 0.04 | Why? |
| Hydroxychloroquine | 1 | 2021 | 12447 | 0.04 | Why? |
| Multiple Trauma | 1 | 2017 | 80 | 0.04 | Why? |
| Injury Severity Score | 1 | 2017 | 287 | 0.04 | Why? |
| Age Factors | 1 | 2018 | 21039 | 0.04 | Why? |
| Intracranial Pressure | 1 | 2016 | 90 | 0.04 | Why? |
| Severity of Illness Index | 3 | 2021 | 48226 | 0.04 | Why? |
| Canada | 2 | 2020 | 6018 | 0.04 | Why? |
| Middle Aged | 9 | 2021 | 270681 | 0.04 | Why? |
| Quality-Adjusted Life Years | 1 | 2019 | 511 | 0.04 | Why? |
| Craniotomy | 1 | 2016 | 123 | 0.04 | Why? |
| Intention to Treat Analysis | 1 | 2017 | 673 | 0.04 | Why? |
| Adult | 11 | 2021 | 244371 | 0.04 | Why? |
| Glycoproteins | 1 | 2020 | 615 | 0.04 | Why? |
| Cross-Over Studies | 1 | 2018 | 867 | 0.04 | Why? |
| Australia | 2 | 2018 | 6306 | 0.04 | Why? |
| Pregnancy Complications, Infectious | 1 | 2021 | 11559 | 0.04 | Why? |
| Overweight | 1 | 2021 | 916 | 0.03 | Why? |
| Transplantation, Homologous | 1 | 2017 | 757 | 0.03 | Why? |
| Pyridones | 1 | 2020 | 738 | 0.03 | Why? |
| Steroids | 1 | 2020 | 904 | 0.03 | Why? |
| Ascorbic Acid | 1 | 2020 | 676 | 0.03 | Why? |
| Patient Participation | 1 | 2021 | 829 | 0.03 | Why? |
| Ultrasonography, Doppler | 1 | 2016 | 406 | 0.03 | Why? |
| Genome-Wide Association Study | 1 | 2020 | 1648 | 0.03 | Why? |
| Statistics, Nonparametric | 1 | 2016 | 1008 | 0.03 | Why? |
| Ireland | 1 | 2018 | 1456 | 0.03 | Why? |
| Shock | 1 | 2020 | 1868 | 0.03 | Why? |
| Pyrimidines | 1 | 2020 | 1557 | 0.03 | Why? |
| Gastrointestinal Hemorrhage | 1 | 2018 | 669 | 0.03 | Why? |
| Combined Modality Therapy | 1 | 2021 | 3395 | 0.03 | Why? |
| Brain Injuries | 1 | 2016 | 374 | 0.03 | Why? |
| Clostridium Infections | 1 | 2018 | 595 | 0.03 | Why? |
| Antioxidants | 1 | 2020 | 1593 | 0.03 | Why? |
| Regression Analysis | 1 | 2016 | 2484 | 0.02 | Why? |
| Odds Ratio | 1 | 2021 | 5861 | 0.02 | Why? |
| Cost-Benefit Analysis | 1 | 2019 | 2259 | 0.02 | Why? |
| United Kingdom | 2 | 2020 | 18046 | 0.02 | Why? |
| Disease Outbreaks | 1 | 2017 | 27595 | 0.02 | Why? |
| Dose-Response Relationship, Drug | 1 | 2018 | 3776 | 0.02 | Why? |
| Body Mass Index | 1 | 2021 | 4306 | 0.02 | Why? |
| International Cooperation | 1 | 2021 | 3436 | 0.02 | Why? |
| Point-of-Care Systems | 1 | 2020 | 2955 | 0.02 | Why? |
| Risk | 1 | 2018 | 5288 | 0.02 | Why? |
| Retrospective Studies | 3 | 2021 | 105322 | 0.02 | Why? |
| Time Factors | 2 | 2018 | 31397 | 0.02 | Why? |
| Cause of Death | 1 | 2018 | 4823 | 0.02 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.02 | Why? |
| Databases, Factual | 1 | 2018 | 6248 | 0.02 | Why? |
| Adrenal Cortex Hormones | 1 | 2020 | 6537 | 0.02 | Why? |
| Prospective Studies | 2 | 2018 | 43301 | 0.02 | Why? |
| Young Adult | 3 | 2019 | 93724 | 0.02 | Why? |
| Drug Repositioning | 1 | 2020 | 5683 | 0.01 | Why? |
| Research Design | 1 | 2018 | 5830 | 0.01 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.01 | Why? |
| Fever | 1 | 2018 | 7795 | 0.01 | Why? |
| Hospitals | 1 | 2021 | 11793 | 0.01 | Why? |
| Length of Stay | 1 | 2018 | 11042 | 0.01 | Why? |
| Patient Acceptance of Health Care | 1 | 2019 | 5002 | 0.01 | Why? |
| Obesity | 1 | 2021 | 7388 | 0.01 | Why? |
| Risk Factors | 2 | 2021 | 71621 | 0.01 | Why? |
| Pregnancy | 1 | 2021 | 23879 | 0.01 | Why? |
| Clinical Trials as Topic | 1 | 2018 | 7330 | 0.01 | Why? |
| Registries | 1 | 2018 | 12327 | 0.01 | Why? |
| Anti-Bacterial Agents | 1 | 2020 | 10083 | 0.01 | Why? |
| Inflammation | 1 | 2020 | 13255 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2016 | 17020 | 0.01 | Why? |
| Cohort Studies | 1 | 2021 | 36005 | 0.01 | Why? |
| Comorbidity | 1 | 2021 | 34796 | 0.01 | Why? |
| Prevalence | 1 | 2016 | 25773 | 0.01 | Why? |
| Hospital Mortality | 1 | 2018 | 22087 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2020 | 53120 | 0.01 | Why? |
| Lung | 1 | 2020 | 31049 | 0.01 | Why? |
| Child | 1 | 2021 | 70012 | 0.01 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.01 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.00 | Why? |
| Aged | 1 | 2018 | 215776 | 0.00 | Why? |
Nichol's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(156)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(1236)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_